No associations seen for preeclampsia or eclampsia or gestational diabetes
MONDAY, Sept. 16, 2024 (HealthDay News) — A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal women, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.
Marie Tan, from the Drexel University College of Medicine in Philadelphia, and colleagues surveyed 383 women presenting for mammogram screening to assess associations between a self-reported history of preeclampsia or eclampsia, gestational hypertension, and gestational diabetes with CVD outcomes in postmenopausal women.
The researchers found that 10.3 percent of women reported a history of CVD, while 2.8 percent reported a history of preeclampsia or eclampsia, 2.1 percent had a history of gestational hypertension, and 3.6 percent had a history of gestational diabetes. There was an association between self-reported history of gestational hypertension and CVD. While a numerically higher prevalence of CVD was seen in women with preeclampsia or eclampsia or all three adverse pregnancy outcomes, these associations were not statistically significant. No association was seen between gestational diabetes and CVD.
“Future research based on a larger sample size is needed to better understand the role adverse pregnancy outcomes may have in cardiovascular disease development and risk stratification,” Tan said in a statement.
Estrogen Hormone Treatment May Be Beneficial for Brain Fog Symptoms in Menopausal Women
Phthalates From Personal Care Products Tied to Higher BP in Pregnancy
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors
Study IDs Gaps in Hereditary Breast Cancer Risk Assessment Before Gender-Affirming Mastectomy